Advertisement
Screener

Celldex Therapeutics, Inc. (CLDX) Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount

2.5 / 5 stars · 46/91 Roast Me

Celldex Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount

Celldex Therapeutics, Inc. (CLDX) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount of -$1.44 million for the 12-month period ending 2022-12-31, per its 10-K filed 2025-02-27.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationTaxContingenciesOther · last filed 2025-02-27

  • Celldex Therapeutics, Inc. effective income tax rate reconciliation, tax contingency, other, amount for fiscal 2022 was -$1.44M.
  • Celldex Therapeutics, Inc. effective income tax rate reconciliation, tax contingency, other, amount for fiscal 2021 was -$295.00K.
  • Celldex Therapeutics, Inc. effective income tax rate reconciliation, tax contingency, other, amount for fiscal 2020 was -$886.00K.
  • Celldex Therapeutics, Inc. effective income tax rate reconciliation, tax contingency, other, amount for fiscal 2019 was -$272.00K.
Period endEffective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount 12 month
2022-12-31-$1.44M
10-K · filed 2025-02-27
2021-12-31-$295.00K
10-K · filed 2024-02-26
2020-12-31-$886.00K
10-K · filed 2023-02-28
2019-12-31-$272.00K
10-K · filed 2022-02-28
2018-12-31-$6.22M
10-K · filed 2021-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93